4 курс / Акушерство и гинекология / Торчинов_А_Р_Современные_технологии_в_лечении_массивных_акушерских

121

136.Franchini M. Potential role of recombinant activated factor VII for the treatment of sever bleedingassociated with disseminated intravascular coagulation: a systematic review // Blood Coagulation and Fibrinolysis. - 2007. - V.18. - P.589.

137.Fuller A.J., Bucklin B.A. Blood product replacement for postpartum hemorrhage // Clin Obstet Gynecol. - 2010. - Vol. 53. - P. 196-208.

138.Gilbert TT, Smulian JC, Martin AA. Obstetric admission to the intensive care unit: outcomes and severity of illness. // Obstet Gynecol. - 2003. - 102: 897.

139.Global patterns of mortality in young people: a systematic analysis of population health data. / Patton GC, Coffey C, Sawyer SM, Viner RM, Haller DM, Bose K, Vos T, Ferguson J, Mathers CD. // Lancet, 2009. 374:881-892.

140.Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage / Welsh A., McLintock C., Gatt S., Somerset D., Popham P., Ogle R. // Aust N Z J Obstet Gynaecol 2008; 48(1): 12-6.

141.Haljamae H. Use of fluids in trauma //International. J Intensive Care. - 1999. - №6 (1). - P. 20-30.

142.Hayman R.G., Arulkumaran S., Steer P.J. Uterine compression sutures: surgical management of postpartum hemorrhage // Obstet Gynecol. - 2002. - Vol.

99.-№3. - P. 502-506.

143.Hull A.D., Resnik R. Placenta accreta and postpartum hemorrhage // Obstet. Gynecol. - 2010. - Vol. 53. - P. 228-236.

144.Karoshi M, Keith L (2009) Challenges in managing postpartum hemorrhage in resource-poor countries. Clin Obstet Gynecol 52: 285-298.

145.Lee J.S, Shepherd S.M. Endovascular treatment of postpartum hemorrhage //Clin Obstet Gynecol. - 2010. - №53. - P. 209-218.

146.Lema V. M. Maternal mortality at the Queen Elizabeth Central Teaching Hospital, Blantyre, Malawi // East. Afr. Med. J. 2005. - Vol.82. - №l. - P. 3-9.

147.Mercier F.J., Van de Velde M. Major obstetric hemorrhage // Anesthesiol. Clin. — 2008. — Vol. 26(1). — P. 53-66.

148.Muller L., Lefrant J.Y., de La Coussaye J.E. Remplissage vasculaire aux urgencies. Quoi de neuf en 2000? // Rev. SAMU. - 2001. - Vol.23. - №1. - P. 7-17.

122

149.Murkin JM. Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis //Transfusion. - 2009. - V.49. - №3. - P. 570-577.

150.Nelson G.S., O'Brien J.M. The uterine sandwich for persistent uterine atony: combining the B-Lynch compression suture and an intrauterine Bakri balloon. Am J Obstet Gynecol 2007; 196; 9-10.

151.Obstetric bleeding: an update / Solaz P.A., Comes F.R., Pitarch L.J.V. et al. // Rev. Esp. Anestesiol. Reanim. - 2010. - Vol. 57(4). - Р. 224-235.

152.Obstetric embolotherapy: effect on menses and pregnancy / A. StancatoPasik, H.A. Mitty, H.M. Richard 3rd [et al.] // Radiology. - 1997. - Vol. 204. - P. 791-793.

153.Penninx J.P.M., Pasmans H.L.M., Oei S.G. Arterial balloon occlusion of the internal iliac arteries for treatment of life-threatening massive postpartum haemorrhage: a series of 15 consecutive cases // Eur J Obstet Gynecol Reprod Biol.

-2010; 148(2): 131-134.

154.Poston, L. Vitamin C and vitamin E in pregnant women at risk for preeclampsia (VIP trial): randomised placebo-controlled trial / L. Poston, A.L. Briley, P.T. Seed // Lancet . - 2006. - Vol. 367. - P. l 145-1154.

155.Postpartum hemmorhage: prevention and treatment by arterial embolization and activated recombinant factor VII / O. Irion, S. Terraz, M. Boulvain [et al.] // Rev. Med. Suisse. - 2008. - V.22. - №4 - P. 2269-2272.

156.Postpartum hemorrhage / Oyelese Y., Scorza W.E., Mastrolia R. et al. // Obstet. Gynecol. Clin. N. Am. - 2007. - Vol. 34(3). - P. 421-441.

157.Postpartum hemorrhage after cesarean delivery: an analysis of risk factors. / Magann E.F., Evans S., Hutchinson M., Collins R., Morrison J.C. // S Med J. - 2005. - Vol. 98. P. 681-685.

158.Postpartum maternal mortality and cesarean delivery / Deneux_Tharaux C., Carmona E., Bouvier_Colle M.H., Breart G. // Obstet Gynecol. - 2006. - Vol. 108. - Р. 541 -548.

123

159.Prendiville W. O’Connell M. Active management of the third stage of labor // A Textbook of Postpartum Hemorrhage. Comprehensive guide to evaluation, management and surgical intervention / Eds Ch.B. Lynch et al. . Sapiens Publishing, 2006. - P. 98-113.

160.Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour (Cochrane Review). In: The Reproductive Health Library, Issue 9, 2006. Oxford: Update Software Ltd. Доступен на сайте: http://www.rhlibrary.com. Перепечатан из: The Cochrane Library, Issue 1, 2006. Chichester, UK: John Wiley & Sons, Ltd.

161.Roman A. S., Rebaber A. Seven ways to control postpartum hemorrhage

//Obstet. Gynecol. - 48(3), 2003.

162.Sagarra M., Glasser S.T., Stone M.L. Ligation of the internal iliac vessels in the control of post_partum hemorrhage. A case report. //Obstet. Gynecol. - 1960. - Vol. 15. - P. 698-701.

163.Shafi S, Kauder DR. Fluid resuscitation and blood replacement in patients with polytrauma //Clin Orthop Relat Res. - 2004; 422: 37-42.

164.Sihler K.C., Napolitano L.M. Massive transfusion // Chest. - 2009. - Vol. 136(6). - Р. 1654-1667.

165.Smith J., Mousa H. A. Peripartum hysterectomy for primary postpartum hemorrhage: incidence and maternal morbidity // J. Obstet. Gynecol. - 2007. - Vol. 27. - P. 44-47.

166.Soltani H., Hutchon D.R., Poulose T.A. Timing of prophylactic uterotonics for the third stage of labour after vaginal birth // Cochrane Database Syst. Rev. - 2010. - Issue 8. - CD006173.

167.Squizzato A., Ageno W. Recombinant activated factor VII as a general haemostatic agent: evidence based efficacy and safety // Curr Drug Saf. - 2007. - V.2. - №2. - Р. 155-161.

168.Successful treatment of life-threatening bleeding after cesarean section with recombinant factor VII / L. Hellman, C. Wild, B. Hojnacki [et al.] // Clin. Appl. Thromb. Hemost. - 2006. - V.12. - P. 227-229.

124

169.The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported / B-Lynch C., Coker A., Lawal A.H. [et al.] // Br J Obstet. Gynaecol. - 1997. - Vol. 104. - P. 372-

170.Uterine necrosis following B-Lynch suture for primary postpartum hemorrhage / E J . Treloar, R.S. Anderson, H.S. Andrews [et al.] // BJOG. - 2006. -

113.- P. 486-488.

171.Weiskopf R.B. Anemia Diagnosis and Evaluation in the Perioperative Setting // Transftision Alternatives in Transfusion Medicine. - 2003. - Vol. 5. - №1.

-P. 20-21.

172.WHO recommendations for the prevention of postpartum haemorrhage: RHL guideline (last revised: 1 May 2010). / Fawole B., Awolude O.A., Adeniji A.O., Onafowokan O. // The WHO Reproductive Health Library; Geneva: World Health Organization.

173.Wingprawat S., Chittacharoen A., Suthutvoravut S. Risk factors for emergency peripartum Caesarean hysterectomy //Int. J. Gynaecol. Obstet. - 2005. -

№90. - P. 136-137.

174.Winograd R.H. Uterine artery embolization for postpartum hemorrhage //Best Pract. Res. Clin. Obstet. Gynaecol. - 2008. - №22. - P. 1119-1132.

175.World Health Organization, UNICEF, UNFPA, World Bank (2012) Trends in Maternal Mortality 1990 to 2010. Geneva, Switzerland: WHO.

176.World Health Organization. WHO guidelines for the management of postpartum haemorrhage and retained placenta. Geneva: WHO; 2009. - P. 55.

177.World Health Organization. WHO recommendations for the prevention and treatment of postpartum hemorrhage. Geneva, Switzerland: World Health Organization. - 2012. - P. 41.

178.Wu H.H, G.P. Yeh. Uterine cavity synechiae after hemostatic square suturing technique //Obstet. Gynecol. - 2005. - 105. - P. 1176-8.